Evopoint Biosciences Adjusts IPO Allocation on Strong Online Demand

MT Newswires Live

Yesterday

Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.

The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.

The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/news/2664385110"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664385110\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664385110?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-04 11:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664385110","market":"fut","top_or_hot":-1,"title":"Evopoint Biosciences Adjusts IPO Allocation on Strong Online Demand","media":"MT Newswires Live","content":"<html><body><p> Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.</p><p>The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.</p><p>The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. <a href=\"https://laohu8.com/S/601211\">Guotai Haitong Securities</a> serves as lead underwriter, with <a href=\"https://laohu8.com/S/CGXYF\">China Galaxy Securities</a> as joint lead underwriter.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Evopoint Biosciences Adjusts IPO Allocation on Strong Online Demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEvopoint Biosciences Adjusts IPO Allocation on Strong Online Demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-04 11:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.</p><p>The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.</p><p>The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. <a href=\"https://laohu8.com/S/601211\">Guotai Haitong Securities</a> serves as lead underwriter, with <a href=\"https://laohu8.com/S/CGXYF\">China Galaxy Securities</a> as joint lead underwriter.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4127","symbol_name":"投资银行业与经纪业","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2664385110","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664385110","pubTimestamp":1788491484,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Evopoint Biosciences  moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688837":"信诺维-U","BK4127":"投资银行业与经纪业","FRHC":"Euronext CAC Health Care","REDS":"RPM Republican Senate ETF","KCE":"SPDR KBW Capital Markets ETF","IPOS":"Renaissance International IPO ETF"},"translate_title":"Evopoint Biosciences 因在线需求强劲而调整 IPO 分配","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688837":0.9,"FRHC":1.5,"KCE":1.5,"REDS":1.5,"IPOS":1.5},"content_text":"Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}